Drugs / gramicidin s
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06859281 | Dec 2024 → Dec 2026 expected | pharyngitis | Valenta Pharm JSC | Recruiting | No outcome recorded |
| Phase 1 | NCT06857890 | Dec 2024 → Dec 2026 expected | pharyngitis | Valenta Pharm JSC | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gramicidin s | “gramicidin s” NCT06859281 ↗1“gramicidin s” NCT06857890 ↗ |
| Route | Oral | “lozenges, 1 lozenge to be taken once under fed conditions.” NCT06857890 ↗ |